BUY Supriya Lifescience — Om Mehra, 28 Sept 2026

byOm Mehra, SAMCO SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Sept 2026via CNBC Awaaz.

Entry₹996.9Inferred

Target₹1,060

Stop loss₹978-1.90% risk

Exit₹97828 Sept 2026, 2:00 pm

Stop-loss hit-1.90%

Follow Om Mehra for new calls(24% target hit, 50 closed calls)Get alerts Watch SUPRIYA for new buy/sell callsGet alerts See 1 active Swing call on SUPRIYA See 75 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Sept, 1:49 am IST

5 supporting0 opposing

Supports the BUY call (5)

Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million

NewsGoogle News·27 Sept · yesterday

Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026

NewsGoogle News·25 Sept · 2d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·24 Sept · 4d ago

Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million

NewsGoogle News·20 Sept · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·6 Jul · 3mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Supriya Lifescience Limited — Om Mehra, SAMCO Securities

AI Assessment